How to verify filler brand authenticity when treated in Brazil

Counterfeit or adulterated injectable filler is a documented problem in Brazil — but its distribution is not uniform across the market, and understanding where the risk actually concentrates is the first step in managing it. The concern is real; it is not grounds for avoiding Brazilian aesthetic medicine broadly, but it is grounds for choosing the right clinical setting with care.

Counterfeiting in the Brazilian injectable market occurs almost exclusively in three types of settings: unlicensed beauty salons and aesthetic studios offering injectable services outside any medical framework; online direct-to-consumer channels selling clinic-grade products without a distributor chain; and heavily discounted promoção pricing — where an offer that sits 60-80% below standard market rates frequently signals that something in the supply chain is not what the label claims. Authentic Juvederm Voluma, Restylane Lyft, Sculptra, or Radiesse, procured through ANVISA-authorised distributors, carries a cost floor that makes dramatic discounting arithmetically inconsistent with legitimacy.

Physician-led practices in Brazil operating within the regulated medical system — with a licensed physician (registered with the Conselho Federal de Medicina), a formal clinical space, and procurement through named authorised distributors such as Allergan Estética, Galderma Brasil, Merz Aesthetics Brasil, and Sinclair Pharma Brasil — are sourcing from the same international supply chain that supplies US and EU markets. The regulatory agency, ANVISA (Agência Nacional de Vigilância Sanitária), evaluates and registers these products before they may be legally sold in Brazil, using criteria aligned with FDA and EMA standards.

Patient red flags that warrant walking away before any injection:

• The clinic cannot name the specific brand or product line to be used before the appointment begins
• The product is drawn from a vial or syringe without the original sealed manufacturer's box being visible
• The price for the session is dramatically below what comparably trained physicians charge in the same city
• The practitioner performing the injection is not a licensed physician — injectable filler in Brazil may legally be administered only by medical doctors (and, in some supervised clinical contexts, by licensed dentists operating within their scope)
• The clinic declines to provide any written record of the brand, batch, or expiry of the product used

None of these flags are specific to Brazil — they apply to any jurisdiction. The difference is that Brazil's market is large, its informal economy is visible, and international patients do not always know how to read the local signals. Knowing what to look for closes that gap.

At INTI — the clinic where Dr. Thiago Perfeito practises — product authenticity verification is a standard part of the pre-procedure consultation, not an optional step requested by the patient. The protocol is straightforward and consistent across every filler appointment.

Before the product is drawn, the original sealed manufacturer's box is presented to the patient for inspection. The brand name, specific product line, ANVISA registration number, batch/lot number, expiration date, and manufacturer identity are visible on the packaging. Patients who wish to cross-reference the ANVISA registration number in real time — at consultas.anvisa.gov.br — are invited to do so before the procedure begins. No appointment proceeds until the patient has had the opportunity to review the product.

The batch number and expiration date are recorded in the patient's clinical file as part of the standard clinical documentation. This record persists for the duration of the patient's relationship with the clinic and is accessible if any follow-up question arises — including questions raised months later by a physician in the patient's home country who is managing a delayed reaction or simply reviewing treatment history.

Written documentation stating the brand used, product line, batch number, and expiry date is available on request at any appointment. International patients who wish to share this information with their home-country physician, dermatologist, or aesthetic practitioner are encouraged to do so — the documentation is designed to be legible to any clinician familiar with the international brand names and regulatory standards involved.

All products used at the clinic are sourced exclusively through ANVISA-authorised distributors for each respective brand. The supply chain for Allergan, Galderma, Merz, and Sinclair products in Brazil runs through the same authorised commercial channels as in the United States and Europe. There is no secondary market, no discounted parallel import, and no product without a verifiable ANVISA registration in the patient's file.

Dr. Thiago Perfeito holds CRM-DF 23199 and practises at INTI, located in Lago Sul, Brasília — a premium medical hub that concentrates physician-led aesthetic practices for the city's diplomatic, executive, and international patient community. Appointments are by consultation; the clinical assessment precedes any treatment plan, and the product selection discussion is part of that assessment, not a post-hoc detail.

Updated 23 May 2026